Observational studyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2013
Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.
Observational study in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Article
- Article
- Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?The journal of vascular access · 2024Review
- Analysis of risk factors for late arteriovenous fistula failure and patency rates after angioplasty in hemodialysis patients: a retrospective cohort study.Translational andrology and urology · 2024Article
- The reasons for comparative effectiveness clinical trials of arteriovenous fistula versus graft strategy in older adults on hemodialysis with a catheter.Clinical nephrology · 2023Article
- Observational
- New Frontiers in Vascular Access Practice: From Standardized to Patient-tailored Care and Shared Decision Making.Kidney360 · 2021Review
- Preoperative assessment for percutaneous and open surgical arteriovenous fistula creation in patients for haemodialysis.Clinical kidney journal · 2021Review
- Abnormalities of vascular histology and collagen fiber configuration in patients with advanced chronic kidney disease.The journal of vascular access · 2019Article
- Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.Journal of the American Society of Nephrology : JASN · 2017Article
- Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients.The Korean journal of internal medicine · 2017Review
- Growth arrest of vascular smooth muscle cells in suspension culture using low-acyl gellan gum.In vitro cellular & developmental biology. Animal · 2017Article
- Preoperative graft assessment in aortocoronary bypass surgery.Experimental and therapeutic medicine · 2016Article
- Maintaining a viable vascular access for hemodialysis in an elderly person with diabetes: a journey to live, not just to stay alive.Clinical case reports · 2016Article
- c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae.American journal of physiology. Renal physiology · 2014Article
- Hemodynamic Shear Stress and Endothelial Dysfunction in Hemodialysis Access.The open urology & nephrology journal · 2014Article
- Novel paradigms for dialysis vascular access: Introduction.Clinical journal of the American Society of Nephrology : CJASN · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundArteriovenous grafts (AVGs) are prone to neointimal hyperplasia leading to AVG failure. We hypothesized that pre-existing pathologic abnormalities of the vessels used to create AVGs (including venous intimal hyperplasia, arterial intimal hyperplasia, arterial medial fibrosis, and arterial calcification) are associated with inferior AVG survival. STUDY
designProspective observational study. SETTING &
participantsPatients with chronic kidney disease undergoing placement of a new AVG at a large medical center who had vascular specimens obtained at the time of surgery (n = 76). PREDICTOR: Maximal intimal thickness of the arterial and venous intima, arterial medial fibrosis, and arterial medial calcification. OUTCOME & MEASUREMENTS: Unassisted primary AVG survival (time to first intervention) and frequency of AVG interventions.
results55 patients (72%) underwent interventions and 148 graft interventions occurred during 89.9 years of follow-up (1.65 interventions per graft-year). Unassisted primary AVG survival was not associated significantly with arterial intimal thickness (HR, 0.72; 95% CI, 0.40-1.27; P = 0.3), venous intimal thickness (HR, 0.64; 95% CI, 0.37-1.10; P = 0.1), severe arterial medial fibrosis (HR, 0.58; 95% CI, 0.32-1.06; P = 0.6), or severe arterial calcification (HR, 0.68; 95% CI, 0.37-1.31; P = 0.3). The frequency of AVG interventions per year was associated inversely with arterial intimal thickness (relative risk [RR], 1.99; 95% CI, 1.16-3.42; P < 0.001 for thickness <10 vs. >25 μm), venous intimal thickness (RR, 2.11; 95% CI, 1.39-3.20; P < 0.001 for thickness <5 vs. >10 μm), arterial medial fibrosis (RR, 3.17; 95% CI, 1.96-5.13; P < 0.001 for fibrosis <70% vs. ≥70%), and arterial calcification (RR, 2.12; 95% CI, 1.31-3.43; P = 0.001 for <10% vs. ≥10% calcification). LIMITATIONS: Single-center study. Study may be underpowered to demonstrate differences in unassisted primary AVG survival.
conclusionsPre-existing vascular pathologic abnormalities in patients with chronic kidney disease may not be associated significantly with unassisted primary AVG survival. However, vascular intimal hyperplasia, arterial medial fibrosis, and arterial calcification may be associated with a decreased frequency of AVG interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.